Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotech Business
Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
October 1st, 2008
Profectus BioSciences Inc., a biotechnology company that develops therapeutic and preventative technologies to reduce the morbidity and mortality of viral diseases, announced the appointment of Dr. William Haseltine, PhD, to the company's board of directors. A seasoned expert in innovating life saving drugs and medical devices, Haseltine brings more than thirty years of expertise in science and business development. Dr. Haseltine currently serves as president of the Haseltine Foundation for Medical Sciences and the Arts, a foundation that supports access to high quality health for the poor and middle class of developing countries. He is also the chairman of Haseltine...
Source: Vaccine Weekly (2008-10-01)
|
